This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
MabVax Therapeutics Holdings, Inc.
Drug Names(s): MVT1075 , MVT 1075 , 177Lu-DTPA-HuMab-5B
Description: MVT-1075 (177Lu-DTPA-HuMab-5B) is MabVax's radioimmunotherapy agent. Based on the name, we assume it binds to the 5B1 tumor antigen, but we will update this record with more details if they become available.
Additional information available to subscribers only: